Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge
Authors:
Open Access
- 13 June 2017
- journal article
- review article
- Published by American Society of Hematology in Blood Advances
- Vol. 1 (14) , 981-994
Abstract
Osteonecrosis (ON) represents one of the most common and debilitating sequelae of antileukemic treatment in children and adolescents with acute lymphoblastic leukemia (ALL). Systematic screening strategies can focus on early detection and intervention to prevent ON from progressing to stages associated with pain and functional impairment. These strategies hold promise for reducing ON-associated morbidity without the risk of impairing leukemia control. Herein, we critically reviewed clinical data on pharmacological, nonpharmacological/nonsurgical, and surgical (including cellular) treatment options for ON, which are covered in the literature and/or are conceivable based on the supposed underlying ON pathophysiology. Prevention of ON progression is of paramount importance, and attempts seem to be more effective in early (precollapse) disease status than in late-stage (collapse) ON. Based on the results of ongoing prospective magnetic resonance imaging screening studies, which will hopefully identify those patients with a high risk of ON progression and debilitating sequelae, prospective interventional studies are urgently needed. Although there is still a lack of high-quality studies, based on currently available data, core decompression surgery combined with cellular therapies (eg, employing mesenchymal stem cells) appears most promising for preventing joint infraction in children at high risk of developing late-stage ON.Keywords
This publication has 91 references indexed in Scilit:
- Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthoodHaematologica, 2013
- Weight bearing does not contribute to the development of osteonecrosis of the femoral headInternational Journal of Experimental Pathology, 2012
- Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaBlood, 2011
- The Repair Process of Osteonecrosis After a Transtrochanteric Rotational OsteotomyClinical Orthopaedics and Related Research, 2010
- Short-Term Bisphosphonate Therapy Could Ameliorate Osteonecrosis: A Complication in Childhood Hematologic MalignanciesCase Reports in Medicine, 2010
- ACTH protects against glucocorticoid-induced osteonecrosis of boneProceedings of the National Academy of Sciences, 2010
- RANK, RANKL and osteoprotegerin in bone biology and diseaseCurrent Reviews in Musculoskeletal Medicine, 2009
- Rationale for prostaglandin I2in bone marrow oedema – from theory to applicationArthritis Research & Therapy, 2008
- Do Modern Techniques Improve Core Decompression Outcomes for Hip Osteonecrosis?Clinical Orthopaedics and Related Research, 2008
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007